Chemed (NYSE:CHE) Price Target Raised to $667.00

Chemed (NYSE:CHE) had its price objective lifted by Royal Bank of Canada from $633.00 to $667.00 in a research note issued on Friday,Benzinga reports. The firm presently has an “outperform” rating on the stock. Royal Bank of Canada’s target price indicates a potential upside of 12.04% from the stock’s current price.

Separately, StockNews.com raised Chemed from a “hold” rating to a “buy” rating in a research report on Friday, March 7th.

Chemed Trading Up 0.9 %

CHE stock traded up $5.35 on Friday, hitting $595.31. 10,272 shares of the company’s stock traded hands, compared to its average volume of 99,362. The stock has a market cap of $8.71 billion, a price-to-earnings ratio of 30.16, a P/E/G ratio of 2.15 and a beta of 0.43. Chemed has a 1-year low of $512.12 and a 1-year high of $654.62. The stock has a fifty day moving average of $559.02 and a 200-day moving average of $564.62.

Insider Activity

In other news, VP Brian C. Judkins bought 145 shares of the stock in a transaction that occurred on Monday, December 30th. The shares were acquired at an average cost of $519.50 per share, for a total transaction of $75,327.50. Following the purchase, the vice president now owns 1,678 shares of the company’s stock, valued at $871,721. This represents a 9.46 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction that occurred on Thursday, March 6th. The shares were sold at an average price of $593.67, for a total value of $1,187,340.00. Following the completion of the sale, the chief executive officer now directly owns 102,679 shares of the company’s stock, valued at $60,957,441.93. This represents a 1.91 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 3.32% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Chemed

Hedge funds have recently made changes to their positions in the company. UMB Bank n.a. boosted its position in Chemed by 300.0% in the 4th quarter. UMB Bank n.a. now owns 52 shares of the company’s stock valued at $28,000 after buying an additional 39 shares during the last quarter. Atala Financial Inc bought a new stake in Chemed during the 4th quarter worth approximately $29,000. CBIZ Investment Advisory Services LLC raised its holdings in shares of Chemed by 64.7% during the fourth quarter. CBIZ Investment Advisory Services LLC now owns 56 shares of the company’s stock worth $30,000 after acquiring an additional 22 shares during the period. Trust Co. of Vermont bought a new position in Chemed during the 4th quarter worth about $34,000. Finally, Tortoise Investment Management LLC raised its position in Chemed by 77.3% in the 4th quarter. Tortoise Investment Management LLC now owns 78 shares of the company’s stock valued at $41,000 after buying an additional 34 shares during the last quarter. Institutional investors and hedge funds own 95.85% of the company’s stock.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.